scispace - formally typeset
M

Manel Almela

Researcher at University of Barcelona

Publications -  80
Citations -  4297

Manel Almela is an academic researcher from University of Barcelona. The author has contributed to research in topics: Vancomycin & Bacteremia. The author has an hindex of 31, co-authored 80 publications receiving 3729 citations.

Papers
More filters
Journal ArticleDOI

Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

TL;DR: Mortality associated with MRSA bacteremia was significantly higher when the empirical antibiotic was inappropriate and when vancomycin was empirically used for treatment of infection with strains with a high vancomYcin MIC (>1 microg/mL).
Journal ArticleDOI

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

Belén Gutiérrez-Gutiérrez, +93 more
TL;DR: Patients with BSIs due to CPE should receive active therapy as soon as they are diagnosed, and monotherapy should be considered for those in the low-mortality-score stratum.
Journal ArticleDOI

Epidemiology, Risk Factors, and Prognosis of Candida parapsilosis Bloodstream Infections: Case-Control Population-Based Surveillance Study of Patients in Barcelona, Spain, from 2002 to 2003

TL;DR: Candida parapsilosis was responsible for 23% of all candidemias and was more frequent in neonates, in transplant recipients, and in patients who received parenteral nutrition or previous antifungal therapy, mainly fluconazole.
Journal ArticleDOI

Non-HACEK gram-negative bacillus endocarditis.

Susan C. Morpeth, +240 more
TL;DR: The ICE-PCS database offers a unique opportunity to evaluate the epidemiology, characteristics, and outcome of endocarditis due to non-HACEK gram-negative bacilli in a large, contemporary, and international cohort of well-characterized patients withendocarditis.